Not finding it? Sign in to also search OpenAlex live.
-
Approaches to improve and adapt maternal mortality estimations in low‐ and middle‐income countries: A scoping review2023 International Journal of Gynecology & Obstetrics article Medicine Global Maternal and Child Health Open access
Maya Tholandi, Siem Zethof, Young Mi Kim, Abera Kenay Tura, Johannes C. F. Ket, Merlin Luke Willcox, +2 more
5citations -
Preoperative [18F]fluoro-PEG-folate PET/CT in advanced stage epithelial ovarian cancer: A safety and feasibility study2024 Nuclear Medicine and Biology article Medicine Ovarian cancer diagnosis and treatment Open access
Isabeau A. Ciggaar, Lysanne D. A. N. de Muynck, Lioe‐Fee de Geus‐Oei, Floris H. P. van Velden, Cor Doede de Kroon, Lenka M. Pereira Arias‐Bouda, +8 more
4citations -
Point-of-Care Ultrasound to Detect Acute Large Vessel Occlusions in Stroke Patients: A Proof-of-Concept Study2022 Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques article Medicine Acute Ischemic Stroke Management
Pardes Habib, Ivaylo Dimitrov, João Pinho, Kolja Schürmann, Jan‐Philipp Bach, Martin Wiesmann, +3 more
3citations -
Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study
Suzanne E N De Vries, Alice M. Couwenberg, Corrie A.M. Marijnen, Geerard L. Beets, Jacobus W. A. Burger, Myriam Chalabi, +6 more
3citations -
MOTION: A randomized, phase 3, placebo-controlled, double-blind study of vimseltinib (DCC-3014) for the treatment of tenosynovial giant cell tumor.2022 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments cited by 11 patents
William D. Tap, Andrew J. Wagner, Maitreyi G. Sharma, Marc Vallee, Mary F. Michenzie, Matthew Leigh Sherman, +4 more
3citations -
Abstract P056: Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance2021 Molecular Cancer Therapeutics conference-abstract Medicine PARP inhibition in cancer therapy cited by 1 patent
Diana A. Zatreanu, Helen M.R. Robinson, Omar Alkhatib, Marie Boursier, Harry Finch, Lerin Geo, +42 more
3citations -
Tub-010, a Novel Antibody-Drug-Conjugate with Reduced Nonspecific Toxicity Profile Based on Tub-Tag Technology Widens the Therapeutic Window for the Treatment of CD30+ Malignancies
Marcus Gerlach, Saskia Schmitt, Philipp Cyprys, Marc‐André Kasper, Isabelle Mai, Maarten H. Vermeer, +5 more
3citations -
Trastuzumab Deruxtecan Versus Ramucirumab-Paclitaxel as Second-Line Therapy for Patients With HER2-Positive Gastric or GEJ Adenocarcinoma2025 Journal of the National Comprehensive Cancer Network article Medicine Gastric Cancer Management and Outcomes Open access
Rob H.A. Verhoeven, Steven C. Kuijper, Florian Lordick, Marije Slingerland, Amy Qin, Hanneke W.M. van Laarhoven
3citations -
Kidney replacement therapy transitions during the year preceding death2024 Nephrology Dialysis Transplantation article Medicine Dialysis and Renal Disease Management Open access
Micha Jongejan, Martijn J. H. Leegte, Alferso C Abrahams, Marjolijn van Buren, Mattijs Everard Numans, Willem Jan W. Bos, +1 more
2citations -
A Truncated 14-Amino-Acid Myelin Protein-Zero-Targeting Peptide for Fluorescence-Guided Nerve-Preserving Surgery2023 Biomolecules article Medicine Optical Imaging and Spectroscopy Techniques Open access cited by 1 patent
Nataliia Berehova, Maarten P. van Meerbeek, Samaneh Azargoshasb, Danny M. van Willigen, Leon J. Slof, Saeedeh Navaei Lavasani, +3 more
2citations